microRNA-339-5p modulates Na+/I- symporter-mediated radioiodide uptake

Endocrine-Related Cancer

Volumn 22, Issue 1, 2015, Pages 11-21

  Lakshmanan, Aparna ^a   Wojcicka, Anna ^b,c   Kotlarek, Marta ^b   Zhang, Xiaoli ^a   Jazdzewski, Krystian ^b,c   Jhiang, Sissy M ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c UNIVERSITY OF WARSAW   (Poland)

Author keywords

microRNA 339 5p; NIS; Papillary thyroid carcinoma; Radioiodide uptake

Indexed keywords

HYDROCORTISONE; MICRORNA; MICRORNA 195; MICRORNA 339 5P; RADIOACTIVE IODINE; RETINOIC ACID; SODIUM IODIDE SYMPORTER; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; COTRANSPORTER; MIRN339 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; DRUG EFFICACY; GENE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HEK293 CELL LINE; HUMAN; HUMAN CELL; NIS GENE; NONHUMAN; RAT; THYROID CANCER; THYROID PAPILLARY CARCINOMA; ANIMAL; BIOSYNTHESIS; BREAST TUMOR; CARCINOMA; CYTOLOGY; FEMALE; GENETICS; HELA CELL LINE; MCF 7 CELL LINE; METABOLISM; THYROID GLAND; THYROID NEOPLASMS;

3' UNTRANSLATED REGIONS; ANIMALS; BREAST NEOPLASMS; CARCINOMA; FEMALE; HEK293 CELLS; HELA CELLS; HUMANS; IODINE RADIOISOTOPES; MCF-7 CELLS; MICRORNAS; RATS; SYMPORTERS; THYROID GLAND; THYROID NEOPLASMS;

EID: 84923532813     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-14-0439     Document Type: Article

References (44)

1. Akama T, Sue M, Kawashima A, Wu H, Tanigawa K, Suzuki S, Hayashi M, Yoshihara A, Ishido Y, Ishii N et al. 2012 Identification of microRNAs that mediate thyroid cell growth induced by TSH. Molecular Endocrinology 26 493-501. (doi:10.1210/me.2011-1004)
2. Alsayed Y, Uddin S, Mahmud N, Lekmine F, Kalvakolanu DV, Minucci S, Bokoch G & Platanias LC 2001 Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to all-trans-retinoic acid. Journal of Biological Chemistry 276 4012-4019. (doi:10.1074/jbc.M007431200)
3. Beyer S, Lakshmanan A, Liu YY, Zhang X, Wapnir I, Smolenski A & Jhiang S 2011 KT5823 differentially modulates sodium iodide symporter expression, activity, and glycosylation between thyroid and breast cancer cells. Endocrinology 152 782-792. (doi:10.1210/en.2010-0782)
4. Chabre O, Libe R, Assie G, Barreau O, Bertherat J, Bertagna X, Feige JJ & Cherradi N 2013 Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients. Endocrine-Related Cancer 20 579-594. (doi:10.1530/ERC-13-0051)
5. de la Chapelle A & Jazdzewski K 2011 MicroRNAs in thyroid cancer. Journal of Clinical Endocrinology and Metabolism 96 3326-3336. (doi:10.1210/jc.2011-1004)
6. Costamagna E, Garcia B & Santisteban P 2004 The functional interaction between the paired domain transcription factor Pax8 and Smad3 is involved in transforming growth factor-β repression of the sodium/iodide symporter gene. Journal of Biological Chemistry 279 3439-3446. (doi:10.1074/jbc.M307138200)
7. Dima M, Miller KA, Antico-Arciuch VG & Di Cristofano A 2011 Establishment and characterization of cell lines from a novel mouse model of poorly differentiated thyroid carcinoma: powerful tools for basic and preclinical research. Thyroid 21 1001-1007. (doi:10.1089/thy.2011.0030)
8. Fayyad-Kazan H, Bitar N, Najar M, Lewalle P, Fayyad-Kazan M, Badran R, Hamade E, Daher A, Hussein N, ElDirani R et al. 2013 Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia. Journal of Translational Medicine 11 31. (doi:10.1186/1479-5876-11-31)
9. Geiss GK, Bumgarner RE, Birditt B, Dahl T, Dowidar N, Dunaway DL, Fell HP, Ferree S, George RD, Grogan T et al. 2008 Direct multiplexed measurement of gene expression with color-coded probe pairs. Nature Biotechnology 26 317-325. (doi:10.1038/nbt1385)
10. Hausser J & Zavolan M 2014 Identification and consequences of miRNA-target interactions - beyond repression of gene expression. Nature Reviews. Genetics 15 599-612. (doi:10.1038/nrg3765)
11. He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, Calin GA, Liu CG, Franssila K, Suster S et al. 2005 The role of microRNA genes in papillary thyroid carcinoma. PNAS 102 19075-19080. (doi:10.1073/pnas.0509603102)
12. Heneghan HM, Miller N, Kelly R, Newell J & Kerin MJ 2010 Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease. Oncologist 15 673-682. (doi:10.1634/theoncologist.2010-0103)
13. Holm S 1979 A simple sequentially rejective multiple test procedure. Scandinavian Journal of Statistics 6 65-70.
14. Jain M, Zhang L, Boufraqech M, Liu-Chittenden Y, Bussey K, Demeure MJ, Wu X, Su L, Pacak K, Stratakis CA et al. 2014 ZNF367 inhibits cancer progression and is targeted by miR-195. PLoS ONE 9 e101423. (doi:10.1371/journal.pone.0101423)
15. Ju X, Li D, Shi Q, Hou H, Sun N & Shen B 2009 Differential microRNA expression in childhood B-cell precursor acute lymphoblastic leukemia. Pediatric Hematology and Oncology 26 1-10. (doi:10.1080/08880010802378338)
16. Kogai T, Schultz JJ, Johnson LS, Huang M & Brent GA 2000 Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line. PNAS 97 8519-8524. (doi:10.1073/pnas.140217197)
17. Kogai T, Sajid-Crockett S, Newmarch LS, Liu YY & Brent GA 2008 Phosphoinositide-3-kinase inhibition induces sodium/iodide sympor-ter expression in rat thyroid cells and human papillary thyroid cancer cells. Journal of Endocrinology 199 243-252. (doi:10.1677/JOE-08-0333)
18. Krol J, Loedige I & FilipowiczW 2010 The widespread regulation of microRNA biogenesis, function and decay. Nature Reviews. Genetics 11 597-610. (doi:10.1038/nrg2843)
19. - symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes. Journal of Clinical Endocrinology and Metabolism 84 3228-3234. (doi:10.1210/jcem.84.9.5996)
20. Leone V, D'Angelo D, Ferraro A, Pallante P, Rubio I, Santoro M, Croce CM & Fusco A 2011 A TSH-CREB1-microRNA loop is required for thyroid cell growth. Molecular Endocrinology 25 1819-1830. (doi:10.1210/me.2011-0014)
21. Li D, Zhao Y, Liu C, Chen X, Qi Y, Jiang Y, Zou C, Zhang X, Liu S, Wang X et al. 2011 Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer. Clinical Cancer Research 17 1722-1730. (doi:10.1158/1078-0432.CCR-10-1800)
22. Li Y, Zhao W, Bao P, Li C, Ma XQ, Li Y & Chen LA 2014 miR-339-5p inhibits cell migration and invasion and may be associated with the tumor-node-metastasis staging and lymph node metastasis of non-small cell lung cancer. Oncology Letters 8 719-725. (doi:10.3892/ol.2014.2165)
23. Lin X 2003 Regulation of sodium iodide symporter expression/function and tissue-targeted gene transfer of sodium iodide symporter. PhD Thesis. The Ohio State University.
24. Liu YY, Zhang X, Ringel MD & Jhiang SM 2012 Modulation of sodium iodide symporter expression and function by LY294002, Akti-1/2 and rapamycin in thyroid cells. Endocrine-Related Cancer 19 291-304. (doi:10.1530/ERC-11-0288)
25. Maqbool R & Hussain MU 2014 MicroRNAs and human diseases: diagnostic and therapeutic potential. Cell and Tissue Research 358 1-15. (doi:10.1007/s00441-013-1787-3)
26. Marsee DK, Venkateswaran A, Tao H, Vadysirisack D, Zhang Z, Vandre DD & Jhiang SM 2004 Inhibition of heat shock protein 90, a novel RET/PTC1-associated protein, increases radioiodide accumulation in thyroid cells. Journal of Biological Chemistry 279 43990-43997. (doi:10.1074/jbc.M407503200)
27. Nicolussi A, D'Inzeo S, Santulli M, Colletta G & Coppa A 2003 TGF-β control of rat thyroid follicular cells differentiation. Molecular and Cellular Endocrinology 207 1-11. (doi:10.1016/S0303-7207(03)00238-7)
28. Nikiforova MN, Tseng GC, Steward D, Diorio D & Nikiforov YE 2008 MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. Journal of Clinical Endocrinology and Metabolism 93 1600-1608. (doi:10.1210/jc.2007-2696)
29. Ohashi E, Kogai T, Kagechika H & Brent GA 2009 Activation of the PI3 kinase pathway by retinoic acid mediates sodium/iodide symporter induction and iodide transport in MCF-7 breast cancer cells. Cancer Research 69 3443-3450. (doi:10.1158/0008-5472.CAN-08-3234)
30. Ouyang M, Li Y, Ye S, Ma J, Lu L, Lv W, Chang G, Li X, Li Q, Wang S et al. 2014 MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer. PLoS ONE 9 e96228. (doi:10.1371/journal. pone.0096228)
31. Pallante P, Visone R, Ferracin M, Ferraro A, Berlingieri MT, Troncone G, Chiappetta G, Liu CG, Santoro M, Negrini M et al. 2006 MicroRNA deregulation in human thyroid papillary carcinomas. Endocrine-Related Cancer 13 497-508. (doi:10.1677/erc.1.01209)
32. Pallante P, Visone R, Croce CM & Fusco A 2010 Deregulation of microRNA expression in follicular-cell-derived human thyroid carcinomas. Endocrine-Related Cancer 17 F91-F104. (doi:10.1677/ERC-09-0217)
33. - symporter messenger ribonucleic acid levels in FRTL-5 cells. Endocrinology 139 703-712. (doi:10.1210/endo.139.2.5760)
34. Pesole G, Grillo G, Larizza A & Liuni S 2000 The untranslated regions of eukaryotic mRNAs: structure, function, evolution and bioinformatic tools for their analysis. Briefings in Bioinformatics 1 236-249. (doi:10.1093/bib/1.3.236)
35. Pizzimenti S, Ferracin M, Sabbioni S, Toaldo C, Pettazzoni P, Dianzani MU, Negrini M & Barrera G 2009 MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation. Free Radical Biology & Medicine 46 282-288. (doi:10.1016/j.freeradbiomed.2008.10.035)
36. Soon PS, Tacon LJ, Gill AJ, Bambach CP, Sywak MS, Campbell PR, Yeh MW, Wong SG, Clifton-Bligh RJ, Robinson BG et al. 2009 miR-195 and miR-483-5p identified as predictors of poor prognosis in adrenocortical cancer. Clinical Cancer Research 15 7684-7692. (doi:10.1158/1078-0432.CCR-09-1587)
37. Swierniak M, Wojcicka A, Czetwertynska M, Stachlewska E, Maciag M, Wiechno W, Gornicka B, Bogdanska M, Koperski L, de la Chapelle A et al. 2013 In-depth characterization of the microRNA transcriptome in normal thyroid and papillary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 98 E1401-E1409. (doi:10.1210/jc. 2013-1214)
38. Tetzlaff MT, Liu A, Xu X, Master SR, Baldwin DA, Tobias JW, Livolsi VA & Baloch ZW 2007 Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues. Endocrine Pathology 18 163-173. (doi:10.1007/s12022-007-0023-7)
39. Ueda R, Kohanbash G, Sasaki K, Fujita M, Zhu X, Kastenhuber ER, McDonald HA, Potter DM, Hamilton RL, Lotze MT et al. 2009 Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1. PNAS 106 10746-10751. (doi:10.1073/pnas.0811817106)
40. Ulivi P, Foschi G, Mengozzi M, Scarpi E, Silvestrini R, Amadori D & Zoli W 2013 Peripheral blood miR-328 expression as a potential biomarker for the early diagnosis of NSCLC. International Journal of Molecular Sciences 14 10332-10342. (doi:10.3390/ijms140510332)
41. Vadysirisack DD, Venkateswaran A, Zhang Z & Jhiang SM 2007 MEK signaling modulates sodium iodide symporter at multiple levels and in a paradoxical manner. Endocrine-Related Cancer 14 421-432. (doi:10.1677/erc.1.01263)
42. Wu ZS, Wu Q, Wang CQ, Wang XN, Wang Y, Zhao JJ, Mao SS, Zhang GH, Zhang N & Xu XC 2010 MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis. BMC Cancer 10 542. (doi:10.1186/1471-2407-10-542)
43. Wyman SK, Knouf EC, Parkin RK, Fritz BR, Lin DW, Dennis LM, Krouse MA, Webster PJ & Tewari M 2011 Post-transcriptional generation of miRNA variants by multiple nucleotidyl transferases contributes to miRNA transcriptome complexity. Genome Research 21 1450-1461. (doi:10.1101/gr.118059.110)
44. Yang G, Wu D, Zhu J, Jiang O, Shi Q, Tian J & Weng Y 2013 Upregulation of miR-195 increases the sensitivity of breast cancer cells to adriamycin treatment through inhibition of Raf-1. Oncology Reports 30 877-889. (doi:10.3892/or.2013.2532)